How We Started

Next Vision Healthcare Consulting™ began with a clear belief: that healthcare strategy should be smarter, faster, and more grounded inexecution. Founder Daanyaal Bandukwala built NVHC to challenge the status quo by offering consulting that blends depth, clarity, and partnership.

At Next Vision, we do not just design strategy. We bring it to life. Our mission is simple: turn vision into reality. Whether we are supporting a launch, navigating market complexity, or building competitive strategy from the ground up, we embed ourselves as true partners. We move quickly, think deeply, and deliver with purpose because great ideas only matter if they make an impact.”

— Daanyaal Bandukwala, Founder and Managing Director

Founders Message

Guiding Principles

  • EMPOWERMENT - We empower pharma, healthcare, and biotech ventures with strategic insights and actionable plans.

  • COLLABORATION - We foster collaboration with partners and clients, crafting tailored solutions that drive healthcare innovation.

  • OUR CORE VALUES - Collaboration, innovation, integrity, excellence, and respect guide us in building lasting relationships.

Our Growth Journey

2022 – Strategic Expansion & Deepened Specialization

  • Led high-impact biosimilar strategy projects, including pricing frameworks, clinic conversion models, and field training integration.

  • Expanded footprint in key therapeutic areas including ophthalmology, oncology, and multiple sclerosis.

  • Delivered customized competitive planning workshops and scenario-based simulations for brand teams preparing for LOE and market disruption.

  • Established a reputation for clear, executable strategy that aligns cross-functional teams and accelerates decision-making.

2023 – Framework Development & Team Growth

  • Developed proprietary strategic tools including:

    • Adoption ladders to guide market entry and physician engagement.

    • Go-to-market roadmaps tailored to Canadian market dynamics.

    • Trade and distribution playbooks to optimize access and inventory management.

  • Built internal infrastructure for scalable consulting delivery, including repeatable workshop templates and client engagement models.

  • Expanded the consulting team with an internship and junior analyst program

  • Provided launch planning, lifecycle strategy,

2024 – Broader Reach & Thought Leadership

  • Expanded consulting work across therapeutic areas such as GI, ophthalmology, cardiology, and specialty access.

  • Facilitated large-scale strategic workshops focused on biosimilar competition, distribution resilience, pre-filled syringe optimization, and future-state access planning.

  • Integrated AI-enabled workflows into research and scenario planning to increase efficiency and insight depth.

  • Rolled out digital-first formats for strategic deliverables and virtual workshop facilitation.

  • Strengthened reputation for fast, focused, and frictionless strategy delivery with measurable impact.

2025 – Innovation & Global Ambitions

  • Began supporting cross-border projects and exploring international expansion, including entry into select Middle East markets.

  • Launched branded service offerings such as:

    • Switch Strategy™

    • Competitive Edge Blueprint™

    • Launch Velocity Workshops™

  • Formalized associate consultant and analyst program to support scale and mentorship within the team.

  • Continued to refine Next Vision’s model as a nimble, high-impact alternative to large firms, blending speed, specialization, and real-world execution


Looking Ahead

As we look to the future, our focus at Next Vision Healthcare Consulting™ remains clear. We are committed to growing with purpose while staying true to what sets us apart. Over the next three to five years, our goal is not to become the largest consulting firm in healthcare. It is to be the most trusted, practical, and results-oriented. We will continue to evolve as a strategy partner that blends therapeutic expertise with real-world execution. Our work will remain centered on high-impact areas such as biosimilars, specialty medicine, and distribution, where clarity and action truly matter.

Looking ahead, we are expanding thoughtfully, investing in innovation, and strengthening the internal systems that allow us to deliver quickly and consistently. Most importantly, we will keep showing up as a genuine extension of our clients’ teams. Not just as consultants, but as builders and partners committed to measurable impact.